^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    bioAffinity Technologies

    i
    Other names: bioAffinity Technologies
    Related tests:
    Evidence

    News

    14d
    bioAffinity Technologies presents research findings at CYTO 2023 (bioAffinity Technologies Press Release)
    "bioAffinity Technologies, Inc...will present the poster 'Development of porphyrin-stained polystyrene compensation beads for use on an automated analysis platform' at CYTO 2023, the annual Congress for the International Society for the Advancement of Cytometry (ISAC), in Montréal, Québec, Canada. ISAC’s mission is to advance the impact of cytometry to meet current and emerging challenges in the life, biomedical and physical sciences."
    Clinical data
    |
    CyPath® Lung
    1m
    bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium (Businesswire)
    "The presentation by...bioAffinity Technologies Executive Vice President and Chief Science and Medical Officer, will focus on advancements in CyPath® Lung, the Company’s noninvasive test for detection of early-stage lung cancer. CyPath® Lung uses flow cytometry and artificial intelligence to analyze the lung microenvironment to identify cell populations that accurately predict cancer in patients at high risk for lung cancer."
    Clinical data
    |
    CyPath® Lung